181 related articles for article (PubMed ID: 32132740)
1. A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO.
Feng JF; Wang L; Jiang YH; Yang X
Rev Invest Clin; 2020; 72(1):46-54. PubMed ID: 32132740
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer.
Tang S; Lin L; Cheng J; Zhao J; Xuan Q; Shao J; Zhou Y; Zhang Y
BMC Cancer; 2020 May; 20(1):382. PubMed ID: 32375697
[TBL] [Abstract][Full Text] [Related]
3. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio.
Lv Y; Zhang J; Liu Z; Tian Y; Liu F
Medicine (Baltimore); 2019 Feb; 98(7):e14562. PubMed ID: 30762804
[TBL] [Abstract][Full Text] [Related]
4. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
[TBL] [Abstract][Full Text] [Related]
5. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
6. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
Sun DW; An L; Lv GY
World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
[TBL] [Abstract][Full Text] [Related]
7. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
9. Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma.
Peng MY; Zuo ZG; Cao FJ; Yu YD; Cai XJ; Wan GX
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557010
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.
Feng JF; Wang L; Chen QX; Yang X
Cancer Control; 2022; 29():10732748221091394. PubMed ID: 35410489
[TBL] [Abstract][Full Text] [Related]
11. Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19-9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma.
Liao YC; Fu M; Wang XF; Cheng XX
J Clin Lab Anal; 2021 May; 35(5):e23757. PubMed ID: 33734488
[TBL] [Abstract][Full Text] [Related]
12. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
Chen S; Yang X; Feng JF
Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Preoperative Fibrinogen-to-Prealbumin Ratio in Patients with Stage I-III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study.
Hailun Xie ; Huang S; Yuan G; Tang S; Gan J
Biomed Res Int; 2021; 2021():3905353. PubMed ID: 33521127
[TBL] [Abstract][Full Text] [Related]
14. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
Sun SY; Chen PP; Meng LX; Li L; Mo ZX; Sun CH; Wang Y; Liang FH
Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29905761
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinoma.
Feng J; Wang L; Yang X; Chen Q
Bosn J Basic Med Sci; 2022 Jun; 22(3):460-470. PubMed ID: 34676808
[TBL] [Abstract][Full Text] [Related]
16. C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma.
Feng JF; Wang L; Jiang YH; Yang X
J Oncol; 2019; 2019():4359103. PubMed ID: 31379941
[TBL] [Abstract][Full Text] [Related]
17. The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X
Bosn J Basic Med Sci; 2021 Dec; 21(6):773-781. PubMed ID: 33974528
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen-to-prealbumin and C-reactive protein-to-prealbumin ratios as prognostic indicators in severe fever with thrombocytopenia syndrome.
Zhang F; Liu XY; Qiao JP; He WT
Front Cell Infect Microbiol; 2024; 14():1397789. PubMed ID: 38915920
[TBL] [Abstract][Full Text] [Related]
19. Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma.
Liang L; Liu F; Yang W; Yang W; Chen L; He Y; Liu Z; Zhang L; Zhang F; Cai F; Xu H; Lin M; Liu M; Pan Y; Liu Y; Hu Z; Chen H; He Z; Ke Y
Ann Surg Oncol; 2022 Sep; 29(9):5626-5633. PubMed ID: 35181817
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
